Skip to main content

Ashley Ghiaseddin, MD : Research

Neuro-Oncologist (Brain Cancer Specialist)

Rated 5.0 out of 5 stars
Photo of Ashley Ghiaseddin

Research at a glance

Top areas of exploration

  • Brain Neoplasms , 14 publications
  • Glioblastoma , 7 publications
  • Tumor Microenvironment , 4 publications
  • Glioma , 4 publications

Research activity

40 publications

389 citations

Why is this important?

Active clinical trials

Nuvation Bio SIGMA (AB-218-G203): Safusidenib Phase 3 study in IDH1-mutant glioma

This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) Grade 2 or…

Investigator
Ashley Ghiaseddin
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
OPTIMUS PRIME - Laser Ablation Surgery and Pembrolizumab for Recurrent Glioblastoma

In this study we are evaluating the safety and feasibility of the triple combination (TTFields, MLA, pembrolizumab) in adult patients diagnosed with recurrent or progressive glioblastoma (GBM) WHO Grade IV, IDH wild type or recurrent or progressive…

Investigator
Ashley Ghiaseddin
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All

My publications

40 publications

2026

Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors

Journal of Pain and Symptom Management

Publisher's site

2026

Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer Immunotherapy

Cancers

Publisher's site

2026

Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice Experiment.

The patient

PubMed • Publisher's site

2026

Real-world mortality and the effect of comorbidities on survival in glioblastoma: A database study using computed phenotypes for rapid, reliable patient identification.

Neuro-oncology advances

PubMed • Publisher's site